106.68
Kymera Therapeutics Inc Azioni (KYMR) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
89.15%
65.00
|
34.37 | 2.87 | 2.764 | 11.48 |
| Cost Of Revenue |
89.15%
65.00
|
34.37 | 2.87 | 2.764 | 11.48 |
| Operating Expenses |
18.64%
140.61
|
118.52 | 100.77 | 95.28 | 96.03 |
| Operating Income/Loss |
10.16%
-75.61
|
-84.15 | -97.90 | -92.52 | -84.56 |
|
|
11.59%
-61.21
|
-69.23 | -86.98 | -82.17 | -76.61 |
| Basic Average Shares |
0.66%
98.18
|
97.53 | 1.8374 | 87.30 | 80.45 |
| Diluted Average Shares |
0.66%
98.18
|
97.53 | 1.8374 | 87.30 | 80.45 |
| Basic Earnings Per Share |
12.68%
-0.62
|
-0.71 | -0.98 | -0.94 | -0.95 |
| Diluted Earnings Per Share |
12.68%
-0.62
|
-0.71 | -0.98 | -0.94 | -0.95 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):